April 5, 2018 / 3:43 PM / 7 months ago

BRIEF-GlaxoSmithKline Inc Says Trelegy Ellipta Approved In Canada

April 5 (Reuters) - GlaxoSmithKline Inc:

* TRELEGY ELLIPTA APPROVED IN CANADA AS FIRST INHALER FOR LONG-TERM, ONCE DAILY TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

* TRELEGY ELLIPTA AVAILABILITY IS EXPECTED JUNE 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below